{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:11:48Z","timestamp":1788909108046,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.acuroe.2025.501748","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:14:09Z","timestamp":1745061249000},"page":"501748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbiota and prostate cancer: An analysis of bacterial communities across various clinical scenarios"],"prefix":"10.1016","volume":"49","author":[{"given":"M.","family":"Carballo Quint\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Perez Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Freire Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Davi\u00f1a Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bellas Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Cabrera Alvargonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Perez Schoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Muller Arteaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Sanchez Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cesp\u00f3n Outeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lopez Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2025.501748_bib0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41571-023-00785-8","article-title":"Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy","volume":"20","author":"Thomas","year":"2023","journal-title":"Nat Rev Clin Oncol."},{"key":"10.1016\/j.acuroe.2025.501748_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298764","article-title":"Prostate cancer in Spain: a retrospective database analysis of hospital incidence and the direct medical costs","volume":"19","author":"Darb\u00e0","year":"2024","journal-title":"PLoS One."},{"key":"10.1016\/j.acuroe.2025.501748_bib0015","series-title":"The microbiota in gastrointestinal pathophysiology: implications for human health, prebiotics, probiotics, and dysbiosis","first-page":"37","article-title":"Identification of the microbiota in the aging process","author":"Sarkar","year":"2017"},{"key":"10.1016\/j.acuroe.2025.501748_bib0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.euf.2016.08.010","article-title":"Inflammation, microbiota, and prostate cancer","volume":"2","author":"Puhr","year":"2016","journal-title":"Eur Urol Focus."},{"key":"10.1016\/j.acuroe.2025.501748_bib0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1158\/1055-9965.EPI-21-0766","article-title":"Gut microbiome\u2013dependent metabolic pathways and risk of lethal prostate cancer: prospective analysis of a PLCO Cancer Screening Trial Cohort","volume":"31","author":"Reichard","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prevent."},{"key":"10.1016\/j.acuroe.2025.501748_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1196217","article-title":"Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?","volume":"13","author":"Zha","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.acuroe.2025.501748_bib0035","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3390\/nu13092978","article-title":"Integrating dietary data into microbiome studies: a step forward for nutri-metaomics","volume":"13","author":"Y\u00e1\u00f1ez","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.acuroe.2025.501748_bib0040","unstructured":"16S Metagenomic Sequencing Library Preparation. Illumina, Inc. Available from: http:\/\/support.illumina.com\/documents\/documentation\/chemistry_documentation\/16s\/16s-metagenomic-library-prep-guide-15044223-b.pdf [accessed 4 Nov 2024]."},{"key":"10.1016\/j.acuroe.2025.501748_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13059-022-02655-5","article-title":"LinDA: linear models for differential abundance analysis of microbiome compositional data","volume":"23","author":"Zhou","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.acuroe.2025.501748_bib0050","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1101\/gr.085464.108","article-title":"Microbial community profiling for human microbiome projects: tools, techniques, and challenges","volume":"19","author":"Hamady","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.acuroe.2025.501748_bib0055","first-page":"E1","article-title":"Correction to: processing and analyzing human microbiome data","author":"Zhu","year":"2018","journal-title":"Methods Mol Biol."},{"key":"10.1016\/j.acuroe.2025.501748_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.796025","article-title":"The power of microbiome studies: some considerations on which alpha and beta metrics to use and how to report results","volume":"12","author":"Kers","year":"2022","journal-title":"Front Microbiol."},{"key":"10.1016\/j.acuroe.2025.501748_bib0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.gendis.2017.06.001","article-title":"Hypothesis testing and statistical analysis of microbiome","volume":"4","author":"Xia","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.acuroe.2025.501748_bib0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41596-019-0264-1","article-title":"Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data","volume":"15","author":"Chong","year":"2020","journal-title":"Nat Protoc."},{"key":"10.1016\/j.acuroe.2025.501748_bib0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41391-021-00413-5","article-title":"The microbiome and prostate cancer","volume":"25","author":"Javier-DesLoges","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.acuroe.2025.501748_bib0080","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/iju.14894","article-title":"Gut microbiome and prostate cancer","volume":"29","author":"Fujita","year":"2022","journal-title":"Int J Urol."},{"key":"10.1016\/j.acuroe.2025.501748_bib0085","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/ijms24021511","article-title":"Microbiome and prostate cancer: a novel target for prevention and treatment","volume":"24","author":"Kustrimovic","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.acuroe.2025.501748_bib0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12885-024-12018-x","article-title":"Gut microbiota in patients with prostate cancer: a systematic review and meta-analysis","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer."},{"key":"10.1016\/j.acuroe.2025.501748_bib0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3892\/or.2023.8560","article-title":"The human microbiome links to prostate cancer risk and treatment (Review)","volume":"49","author":"Xia","year":"2023","journal-title":"Oncol Rep."},{"key":"10.1016\/j.acuroe.2025.501748_bib0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13027-020-00319-2","article-title":"The human microbiome and its link in prostate cancer risk and pathogenesis","volume":"15","author":"Katongole","year":"2020","journal-title":"Infect Agent Cancer."},{"key":"10.1016\/j.acuroe.2025.501748_bib0105","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","article-title":"Gut microbiota in colorectal cancer: mechanisms of action and clinical applications","volume":"16","author":"Wong","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.acuroe.2025.501748_bib0110","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41586-022-05181-3","article-title":"Identification of trypsin-degrading commensals in the large intestine","volume":"609","author":"Li","year":"2022","journal-title":"Nature."},{"key":"10.1016\/j.acuroe.2025.501748_bib0115","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3390\/cancers12051142","article-title":"Integrative analysis of fecal metagenomics and metabolomics in colorectal cancer","volume":"12","author":"Clos-Garc\u00eda","year":"2020","journal-title":"Cancers."},{"key":"10.1016\/j.acuroe.2025.501748_bib0120","article-title":"Causal relationship between gut microbiota and prostate cancer contributes to the gut-prostate axis: insights from a Mendelian randomization study","volume":"15","author":"Wang","year":"2024","journal-title":"Discover Oncol."},{"key":"10.1016\/j.acuroe.2025.501748_bib0125","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1053\/j.gastro.2022.07.004","article-title":"Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn\u2019s disease","volume":"163","author":"Leibovitzh","year":"2022","journal-title":"Gastroenterology."},{"key":"10.1016\/j.acuroe.2025.501748_bib0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-023-02761-6","article-title":"Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study","volume":"21","author":"Long","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.acuroe.2025.501748_bib0135","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.3390\/ijms20215295","article-title":"The role of the gut microbiota in colorectal cancer causation","volume":"20","author":"Alhinai","year":"2019","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.acuroe.2025.501748_bib0140","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2269623","article-title":"The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities","volume":"15","author":"Mima","year":"2023","journal-title":"Gut Microbes."},{"key":"10.1016\/j.acuroe.2025.501748_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100928","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization","volume":"43","author":"Liu","year":"2023","journal-title":"Neoplasia."},{"key":"10.1016\/j.acuroe.2025.501748_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115276","article-title":"The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: mechanisms and therapeutic potentials","volume":"165","author":"Duan","year":"2023","journal-title":"Biomed Pharmacother."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578625000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578625000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:26:05Z","timestamp":1762601165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578625000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2173578625000885"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501748","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota and prostate cancer: An analysis of bacterial communities across various clinical scenarios","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2025.501748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501748","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501748"}}